Neurology

Nusinersen Shows Efficacy in Infantile- and Late-Onset Spinal Muscular Atrophy



The new data further cemented the therapy’s consistent safety profile from previous studies as well as demonstrated a newfound durability in patients with later-onset spinal muscular atrophy. 

Source link

Related posts

No Protective Effect of Moderate Drinking on Stroke Risk

Newsemia

Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours

Newsemia

Polyneuropathy in Gaucher disease type 1 and 3 – a descriptive case series

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World